Objective: The authors provide an evidenced-based summary of the literature on the clinical
application of psychedelic drugs in psychiatric disorders. Methods: Searches of PubMed and …

Objective To conduct a systematic review of modern‐era (post‐millennium) clinical studies
assessing the therapeutic effects of serotonergic psychedelics drugs for mental health …

Introduction: Small-scale clinical studies with psychedelic drugs have shown promising
results for the treatment of several mental disorders. Before psychedelics become registered …

Introduction: Mood, anxiety, and substance-use disorders are among the most prevalent
psychiatric disorders in the population. Although several pharmacological treatments are …

This report provides a historical overview of research concerning the endogenous
hallucinogen N, N-dimethyltryptamine (DMT), focusing on data regarding its biosynthesis …

Background: Ayahuasca, a traditional Amazonian decoction with psychoactive properties, is
made from bark of the Banisteriopsis caapi vine (containing beta-carboline alkaloids) and …

Serotoninergic hallucinogens include drugs such as lysergic acid diethylamide (LSD),
dimethyltryptamine (DMT) and psilocybin. Recent trials with single/few doses of these …

Ayahuasca is a hallucinogen brew traditionally used for ritual and therapeutic purposes in
Northwestern Amazon. It is rich in the tryptamine hallucinogens dimethyltryptamine (DMT) …

Ayahuasca is a hallucinogenic botanical beverage originally used by indigenous
Amazonian tribes in religious ceremonies and therapeutic practices. While ethnobotanical …

Though relatively obscure, N, N-dimethyltryptamine (DMT) is an important molecule in
psychopharmacology as it is the archetype for all indole-containing serotonergic …